FdaApplication
NDA 022560
Identifiers
- fda_app_no: NDA022560
Properties
| Property | Value |
|---|---|
| applicant_name | ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD |
| application_type | NDA |
| approval_date | 2010-10-08 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ATELVIA | RISEDRONATE SODIUM | 35MG | TABLET, DELAYED RELEASE;ORAL |
1 product